Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Arterial Hypertension
Interventions
DRUG

Chlorthalidone 25 mg + amiloride hydrochloride 5 mg

Chlorthalidone 25 mg + amiloride hydrochloride 5 mg - one oral tablet a day in the morning during approximately 12 weeks

DRUG

Higroton® Laboratório Novartis

Chlortalidone 25mg - oral tablet a day in the morning during approximately 12 weeks

Trial Locations (10)

Unknown

Centro de Estudos de Diabetes e Hipertensão, Fortaleza

CEDOES - Centro de Diagnóstico e Pesquisa de Osteoporose do Espírito Santo, Vitória

Liga de Hipertensão Arterial - Universidade Federal de Goiás, Goiânia

UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina - UNESP, Botucatu

Centro de Pesquisa Clínica do IMC - Instituto de Moléstias Cardiovasculares, São José do Rio Preto

Instituto de Moléstias Cardiovasculares de Tatuí, Tatuí

Clínica Paulista de Doenças Cardiovasculares - FGM, São Paulo

Hospital Santa Marcelina, São Paulo

Hospital São Camilo, São Paulo

IMA - Instituto de Medicina Avançada, São Paulo

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY